Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis - Ringlike appearances in acute plaques

Acta Radiologica

Volumn 37, Issue 3, 1996, Pages 278-287

  Landtblom, A M ^a   Sjoqvist L ^a   Soderfeldt B ^a   Nyland, H ^b   Thuomas, K A ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Brain; MR spectroscopy; Multiple sclerosis

Indexed keywords

ASPARTIC ACID; CHOLINE; CREATINE; CREATINE PHOSPHATE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INOSITOL; LACTIC ACID; LACTIC ACID DERIVATIVE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; AGED; ARTICLE; BRAIN; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ADULT; AGED; ASPARTIC ACID; BRAIN; CASE-CONTROL STUDIES; CHOLINE; CREATINE; FEMALE; HUMANS; INOSITOL; LACTATES; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHOSPHOCREATINE;

EID: 0030136828     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859609177651     Document Type: Article

References (27)

1. ADAMS C. W. M.: Inflammatory vasculitis in multiple sclerosis. J. Neurol. Sci. 69 (1985), 269.
2. ARNOLD D. L., MATTHEWS P. M. & FRANCIS G. S.: Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 31 (1992), 235.
3. ARNOLD D. L., MATTHEWS P. M., FRANCIS G. & ANTEL J.: Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis. Assessment of the load of disease. Magn. Reson. Med. 14 (1990), 154.
4. ARNOLD D. L., RIESS G. T., MATTHEWS P. M. et al.: Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann. Neurol. 36 (1994), 76.
5. BABIOR M. B.: Oxygen-dependent microbial killing of phagocytes. N. Engl. J. Med. 298 (1978), 659.
6. BALÒ J.: Encephalitis periaxialis concentrica. Arch. Neurol. Psychiatry 19 (1928), 242.
7. BARBOSA S., BLUMBARDT L. D., ROBERTS N. & EDWARDS R. H. T.: Magnetic resonance relaxation time mapping in multiple sclerosis. Normal appearing white matter and the invisible lesion load. Magn. Reson. Imaging 12 (1994), 33.
8. BRUHN H., FRAHM J., MERBOLDT K. D. et al.: Multiple sclerosis in children. Cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann. Neurol. 32 (1992), 140.
9. CADOUX-HANSEN T. A., KERMODE A., RAJAGOPALAN B. et al.: Biochemical changes within a multiple sclerosis plaque in vivo. J. Neurol. Neurosurg. Psychiatry 54 (1991), 1004.
10. CHRISTIANSEN P., GIDEON P., THOMSEN C., STUBGAARD M., HENRIKSEN O. & LARSSON H. B.: Increased water self diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol. Scand. 87 (1993), 195.
11. DAVIE C. A., HAWKINS C. P., BARKER G. J. et al.: Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 341 (1993), 630.
12. DAVIE C. A., HAWKINS C. P., BARKER G. J. et al.: Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 177 (1994), 49.
13. ESIRI M. M. & OPPENHEIMER D. R.: Diagnostic neuropathology. Blackwell Scientific, Oxford 1989.
14. FILIPPI M., HORSFIELD M. A., MORISSEY S. P. et al.: Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44 (1994), 635.
15. GROSSMAN R. I., LENKINSKI R. E., RAMER K. N., GONZALES-SCARANO F. & COHEN J. A.: MR proton spectroscopy in multiple sclerosis. AJNR 13 (1992), 1535.
16. HAIMES A. B., ZIMMERMAN R. D., MORGELLO S. et al.: MR imaging of brain abscesses. AJNR 10 (1989), 279.
17. HENRIKSEN O., GIDEON O., SPERLING B., SKYHØJ OLSEN T., JØRGENSEN H. S. & ARLIEN-SØBORG P.: Cerebral lactate production and blood flow in acute stroke. J. Magn. Reson. Imaging 2 (1992), 511.
18. HILLERT J., GRÖNNING M., NYLAND H., LINK H. & OLERUP O.: An immunogenetic heterogeneity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 55 (1992), 887.
19. KATZ D., TAUBENBERGER J. K., CANELLA B., MCFARLIN D. E., RAINE C. S. & MCFARLAND H. F.: Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann. Neurol. 34 (1993), 661.
20. KIDD D., REVECZ T. R., THOMPSON A. J. & MCDONALD W. I.: A comparative clinicopathological study of progressive multiple sclerosis [Abstract]. Ann. Neurol. 34 (1993), 308.
21. KURTZKE J. F.: Rating neurological impairment in multiple sclerosis. An expanded disability status scale (EDSS). Neurology 33 (1983), 1444.
22. KOOPMANS R. A., LI D. K. B., ZHU G., ALLEN P. S., PENN A. & PATY D. W.: Magnetic resonance spectroscopy of multiple sclerosis. In-vivo detection of myelin breakdown products. Lancet 341 (1993), 631.
23. LARSSON H. B., CHRISTIANSEN P., JENSEN M. et al.: Localized m vivo proton spectroscopy in the brains of patients with multiple sclerosis. Magn. Reson. Med. 22 (1991), 23.
24. LARSSON H. B., THOMSEN C., FREDERIKSEN J., STUBGAARD M. & HENRIKSEN O.: In vivo magnetic resonance diffusion measurements in the brains of patients with multiple sclerosis. Magn. Reson. Imaging 10 (1992), 7.
25. MATTHEWS J. F.: Clinical aspects. In: McAlpine's multiple sclerosis, p. 43. Edited by J. F. Matthews. W. B. Churchill Livingstone, Edinburgh 1991.
26. MATTHEWS P. M., FRANCIS G., ANTEL J. & ARNOLD D. L.: Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41 (1991), 1251.
27. MCALPINE D.: Course and prognosis of multiple sclerosis. In: Multiple sclerosis, p. 135. Edited by D. McAlpine, N. D. Compston & C. E. Lunsden. ENS Livingstone, Edinburgh 1955.